Skip to content
2000
image of Therapeutic Potential of Mesenchymal Stem Cells or their Secretome in Diabetic Mice with or without Preconditioning Treatment

Abstract

Background

Type 1 diabetes mellitus (T1DM) is an autoimmune disease with difficult management, affecting the quality of life. Stem cell therapy has been proven to have regenerative ability. Using the existing stem cell therapy and modifying it, the current study aims to evaluate the effect of umbilical cord-derived mesenchymal stem cells (UCMSC), condition media (CM), and UCMSC and CM preconditioned with methotrexate, reservetrol, and vitamin D for its ability to manage T1DM in Swiss albino mice.

Materials & Methods

Disease condition was established in the animals by using a diabetes-inducing agent streptozotocin (STZ). Then the animals were grouped into normal control, disease control, standard, and test groups; and the treatments were given accordingly. The total study period for this experiment was 28 days. During this period, the animals were supervised for blood glucose levels, food-water intake, and body weight twice a week. At the end of 28 days, the biochemical estimations for serum insulin level, C-peptide, pro-inflammatory cytokines, and anti-inflammatory cytokines level were done. Also, histopathology of the pancreas was performed.

Results

The test groups showed a significant decline in the blood glucose level, an increasein C-peptide level, and a decrease in pro-inflammatory cytokines as compared to the disease group. A statistically significant change was not observed within the groups in terms of serum insulin and anti-inflammatory cytokine levels. There were improvements in diabetic symptoms in treatment groups, such as polyphagia, polydipsia, and weightloss. Treatment groups also showed pancreatic regeneration, indicating improved insulin secretion.

Conclusion

In the present study, we concluded that UCMSC, CM, and UCMSC and CMpreconditioned with synthetic and natural immunosuppressants and immunomodulators havethe ability to regenerate damaged pancreatic beta cells and have an antidiabetic activity, along with an immunomodulating effect. This therapy is a promising choice for future research.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raiad/10.2174/0127722708323777250121224618
2025-02-07
2025-09-02

  • From This Site

    /content/journals/raiad/10.2174/0127722708323777250121224618
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ramachandran A. Know the signs and symptoms of diabetes. Indian J. Med. Res. 2014 140 5 579 581 25579136
    [Google Scholar]
  2. Sapra A. Bhandari P. Diabetes Mellitus. StatPearls. Treasure Island, FL: StatPearls Publishing 2023 Updated 2022 Jun 26 Available From: https://www.ncbi.nlm.nih.gov/books/NBK551501/
    [Google Scholar]
  3. Hashemi S.M. Hassan Z.M. Hossein-Khannazer N. Pourfathollah A.A. Soudi S. Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice. Inflammopharmacology 2020 28 2 585 601 10.1007/s10787‑019‑00661‑x 31741175
    [Google Scholar]
  4. Tremblay J. Hamet P. Environmental and genetic contributions to diabetes. Metabolism 2019 100 153952 10.1016/j.metabol.2019.153952 31610851
    [Google Scholar]
  5. Gregory G.A. Robinson T.I.G. Linklater S.E. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study. Lancet Diabetes Endocrinol. 2022 10 10 741 760 10.1016/S2213‑8587(22)00218‑2 36113507
    [Google Scholar]
  6. Chen S. Du K. Zou C. Current progress in stem cell therapy for type 1 diabetes mellitus. Stem Cell Res. Ther. 2020 11 1 275 10.1186/s13287‑020‑01793‑6 32641151
    [Google Scholar]
  7. Akil A.A.S. Yassin E. Al-Maraghi A. Aliyev E. Al-Malki K. Fakhro K.A. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. J. Transl. Med. 2021 19 1 137 10.1186/s12967‑021‑02778‑6 33794915
    [Google Scholar]
  8. Shah A.A. Khan F.A. Types and Classification of Stem Cells. Advances in Application of Stem Cells: From Bench to Clinics Stem Cell Biology and Regenerative Medicine. Cham Humana 2021 69 10.1007/978‑3‑030‑78101‑9_2
    [Google Scholar]
  9. Zakrzewski W. Dobrzyński M. Szymonowicz M. Rybak Z. Stem cells: Past, present, and future. Stem Cell Res. Ther. 2019 10 1 68 10.1186/s13287‑019‑1165‑5 30808416
    [Google Scholar]
  10. Patil V.R. Kharat A.H. Kulkarni D.G. Kheur S.M. Bhonde R.R. Long term explant culture for harvesting homogeneous population of human dental pulp stem cells. Cell Biol. Int. 2018 42 12 1602 1610 10.1002/cbin.11065 30353965
    [Google Scholar]
  11. Furman BL Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol 2015 70 5.47.1 5.47.20 10.1002/0471141755.ph0547s70 26331889
    [Google Scholar]
  12. Russo G.T. Minutoli L. Bitto A. Methotrexate increases skeletal muscle GLUT4 expression and improves metabolic control in experimental diabetes. J. Nutr. Metab. 2012 2012 1 7 10.1155/2012/132056 22778921
    [Google Scholar]
  13. Lee S.M. Yang H. Tartar D.M. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011 54 5 1136 1146 10.1007/s00125‑011‑2064‑1 21340626
    [Google Scholar]
  14. Yu J. Sharma P. Girgis C.M. Gunton J.E. Vitamin D and beta cells in type 1 diabetes: A systematic review. Int. J. Mol. Sci. 2022 23 22 14434 10.3390/ijms232214434 36430915
    [Google Scholar]
  15. Ricci C. Baumgartner J. Malan L. Smuts C.M. Determining sample size adequacy for animal model studies in nutrition research: Limits and ethical challenges of ordinary power calculation procedures. Int. J. Food Sci. Nutr. 2020 71 2 256 264 10.1080/09637486.2019.1646714 31379222
    [Google Scholar]
  16. Hamza R. Al-Eisa R. El-Shenawy N. Efficacy of mesenchymal stem cell and vitamin D in the treatment of diabetes mellitus induced in a rat model: Pancreatic tissues. Coatings 2021 11 3 317 10.3390/coatings11030317
    [Google Scholar]
  17. Jayasinghe M. Prathiraja O. Perera P.B. The role of mesenchymal stem cells in the treatment of type 1 diabetes. Cureus 2022 14 7 e27337 10.7759/cureus.27337 36042996
    [Google Scholar]
  18. Hu J. Yu X. Wang Z. Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr. J. 2013 60 3 347 357 10.1507/endocrj.EJ12‑0343 23154532
    [Google Scholar]
  19. Desai S. Jagtap J. Sainani S. Bhonde R. Guiding stem cells for cutaneous repair. Current Research in Pharmacology and Drug Discovery 2023 4 100145 10.1016/j.crphar.2022.100145 36544814
    [Google Scholar]
  20. Nugroho W.S. Kusindarta D.L. Susetya H. The structural and functional recovery of pancreatic β-cells in type 1 diabetes mellitus induced mesenchymal stem cell-conditioned medium. Vet. World 2016 9 5 535 539 10.14202/vetworld.2016.535‑539 27284233
    [Google Scholar]
  21. Sato Y. Ochiai D. Abe Y. Prophylactic therapy with human amniotic fluid stem cells improved survival in a rat model of lipopolysaccharide-induced neonatal sepsis through immunomodulation via aggregates with peritoneal macrophages. Stem Cell Res. Ther. 2020 11 1 300 10.1186/s13287‑020‑01809‑1 32690106
    [Google Scholar]
  22. Hu C. Li L. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo. J. Cell. Mol. Med. 2018 22 3 1428 1442 10.1111/jcmm.13492 29392844
    [Google Scholar]
  23. Zhang L.X. Li C.X. Kakar M.U. Resveratrol (RV): A pharmacological review and call for further research. Biomed. Pharmacother. 2021 143 112164 10.1016/j.biopha.2021.112164 34649335
    [Google Scholar]
  24. Trung L.Q. An D.T.T. Is resveratrol a cancer immunomodulatory molecule? Front. Pharmacol. 2018 9 1255 10.3389/fphar.2018.01255 30459616
    [Google Scholar]
  25. Shakoor H. Feehan J. Apostolopoulos V. Immunomodulatory effects of dietary polyphenols. Nutrients 2021 13 3 728 10.3390/nu13030728 33668814
    [Google Scholar]
  26. Gianchecchi E. Fierabracci A. Insights on the effects of resveratrol and some of its derivatives in cancer and autoimmunity: A molecule with a dual activity. Antioxidants 2020 9 2 91 10.3390/antiox9020091 31978952
    [Google Scholar]
  27. Hoca M. Becer E. Vatansever H.S. The role of resveratrol in diabetes and obesity associated with insulin resistance. Arch. Physiol. Biochem. 2023 129 2 555 561 10.1080/13813455.2021.1893338 33719825
    [Google Scholar]
  28. Basit S. Vitamin D in health and disease: A literature review. Br. J. Biomed. Sci. 2013 70 4 161 172 10.1080/09674845.2013.11669951 24400428
    [Google Scholar]
  29. Prietl B. Treiber G. Pieber T. Amrein K. Vitamin D and immune function. Nutrients 2013 5 7 2502 2521 10.3390/nu5072502 23857223
    [Google Scholar]
/content/journals/raiad/10.2174/0127722708323777250121224618
Loading
Therapeutic Potential of Mesenchymal Stem Cells or their Secretome in Diabetic Mice with or without Preconditioning Treatment
Bentham Science Publishers ; https://doi.org/10.2174/0127722708323777250121224618
/content/journals/raiad/10.2174/0127722708323777250121224618
/content/journals/raiad/10.2174/0127722708323777250121224618
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: immunomodulation ; Type 1 diabetes mellitus ; streptozotocin model ; umbilical cord-derived mesenchymal stem cells (UCMSC) ; pancreatic regeneration

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test